Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
6 studies found for:    20097417 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Procalcitonin in Early Antibiotic Interruption in Patient With Bacterial Pulmonary infeCtion and Acute Heart Failure
Conditions: Respiratory Tract Infections;   Pneumonia, Bacterial;   Heart Failure
Intervention: Other: Interruption of antibiotic treatment due to PCT measurement
2 Recruiting Impact of the Duration of Antibiotics on Clinical Events in Patients With Pseudomonas Aeruginosa Ventilator-associated Pneumonia (iDIAPASON)
Condition: Ventilator-Associated Pneumonia
Interventions: Drug: 8 days of effective antibiotic treatment;   Drug: 15 days of effective antibiotic treatment
3 Completed Procalcitonin Use in Pneumonia Patients in the Critical Care Setting
Condition: Pneumonia
Intervention: Other: Use of procalcitonin as biomarker to guide therapy
4 Completed Suitability of Antibiotic Treatment for CAP
Condition: Community Acquired Pneumonia
Interventions: Other: Intervention group;   Other: Control group
5 Enrolling by invitation Procalcitonin Monitoring May Decrease Antibiotic Use in the Intensive Care Unit
Condition: Sepsis
Intervention: Other: Literature search
6 Completed PROcalcitonin Reduce Antibiotic Treatments in Acute-Ill Patients (PRORATA)
Condition: Bacterial Infections
Intervention: Procedure: Procalcitonin guided strategy

Indicates status has not been verified in more than two years